SOSTDC1 down-regulation of expression involves CpG methylation and is a potential prognostic marker in gastric cancer

Cancer Genetics

Volumn 206, Issue 5, 2013, Pages 174-182

  Gopal, Gopisetty ^a   Raja, Uthandaraman Mahalinga ^a   Shirley, Sundersingh ^a   Rajalekshmi, Kamlalyam Raghavan ^a   Rajkumar, Thangarajan ^a  

^a CANCER INSTITUTE WIA   (India)

Author keywords

Epigenetics; Gastric cancer; Prognosis; Promoter methylation; SOSTDC1

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MESSENGER RNA; SCLEROSTIN DOMAIN CONTAINING 1 PROTEIN; TRICHOSTATIN A; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DISEASE FREE SURVIVAL; DNA METHYLATION; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MARKER GENE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SCLEROSTIN DOMAIN CONTAINING 1 GENE; STOMACH CANCER; STOMACH TUMOR; TUMOR SUPPRESSOR GENE;

EPIGENETICS; GASTRIC CANCER; PROGNOSIS; PROMOTER METHYLATION; SOSTDC1;

BASE SEQUENCE; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DOWN-REGULATION; GENETIC MARKERS; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROTEINS; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 84881231573     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2013.04.005     Document Type: Article

References (21)

1. Rajkumar T., Vijayalakshmi N., Gopal G., et al. Identification and validation of genes involved in gastric tumorigenesis. Cancer Cell Int 2010, 10:45.
2. Ahn Y., Sanderson B.W., Klein O.D., et al. Inhibition of Wnt signaling by Wise (Sostdc1) and negative feedback from Shh controls tooth number and patterning. Development 2010, 137:3221-3231.
3. Laurikkala J., Kassay Y., Pakkasjarvi L., et al. Identification of a secreted BMP antagonist, ectodin, integrating BMP, FGF, and SHH signals from the tooth enamel knot. Dev Biol 2003, 264:91-105.
4. Shigetani Y., Howard S., Guidato S., et al. Wise promotes coalescence of cells of neural crest and placode origins in the trigeminal region during head development. Dev Biol 2008, 319:346-358.
5. Blish K.R., Wang W., Willingham M.C., et al. Ahuman bone morphogenetic protein antagonist is down-regulated in renal cancer. Mol Biol Cell 2008, 19:457-464.
6. Blish K.R., Clausen K.A., Hawkins G.A., et al. Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors. JExp Clin Cancer Res 2010, 29:147.
7. Ohshima J., Haruta M., Arai Y., et al. Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor. Genes Chromosomes Cancer 2009, 48:1037-1050.
8. Rajkumar T., Stamp G.W., Hughes C.M., et al. c-erbB3 protein expression in ovarian cancer. Clin Mol Pathol 1996, 49:199-202.
9. Singal R., van Wert J., Bashambu M. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells. Cancer Res 2001, 61:4820-4826.
10. Das P.M., Singal R. DNA methylation and cancer. JClin Oncol 2004, 22:4632-4642.
11. Acharya M.R., Sparreboom A., Venitz J., et al. Rational development of histone deacetylase inhibitors as anticancer agents: a review. Mol Pharmacol 2005, 68:917-932.
12. Abbaszadegan M.R., Moaven O., Sima H.R., et al. p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer. World J Gastroenterol 2008, 14:2055-2060.
13. Chen W., GaoN Shen Y., et al. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer. JGastroenterol Hepatol 2010, 25:823-831.
14. Guo X., Liu W., Pan Y., et al. Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma. Oncogene 2010, 29:3908-3920.
15. Bird A.P., Wolffe A. Methylation-induced repression-belts, braces, and chromatin. Cell 1999, 99:451-454.
16. Boyes J., Bird A. Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO J 1992, 11:327-333.
17. Gal-Yam E.N., Egger G., Iniguez L., et al. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci U S A 2008, 105:12979-12984.
18. Han H., Cortez C.C., Yang X., et al. DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter. Hum Mol Genet 2011, 20:4299-4310.
19. Kim S.K., Jang H.R., Kim J.H., et al. The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration. Biochem Biophys Res Commun 2006, 349:1032-1040.
20. Grady W.M., Willis J., Guilford P.J., et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 2000, 26:16-17.
21. Clausen K.A., Blish K.R., Birse C.E., et al. SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer. Breast Cancer Res Treat 2011, 129:737-746.